30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Acurx Pharmaceuticals Inc (ACXP)

Track

Stock chart
Ticker: ACXP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sailer Carl
1 purchase — total 25,000 USD
Buy 6 Jan 2025
Value US$3,074,389.11 | Price 57.10 | Shares 29,323
Buy 6 Jan 2025
Value US$2,953,103.02 | Price 304.16 | Shares 10,979
Buy 6 Jan 2025
Value US$9,999.78 | Price 1.02 | Shares 9,852
Buy 6 Jan 2025
Value US$25,000.46 | Price 1.02 | Shares 24,631
Buy 6 Jan 2025
Value US$49,999.92 | Price 1.02 | Shares 49,261
Buy 6 Jan 2025
Value US$49,999.92 | Price 1.02 | Shares 49,261
Buy 27 Jul 2022
Value US$75,000.60 | Price 3.80 | Shares 19,737
Buy 27 Jul 2022
Value US$75,000.60 | Price 3.80 | Shares 19,737
Buy 27 Jul 2022
Value US$75,000.60 | Price 3.80 | Shares 19,737
Buy 23 Nov 2021
Value US$24,979.24 | Price 4.84 | Shares 5,161
Buy 19 Nov 2021
Value US$24,671.63 | Price 4.90 | Shares 5,034
Buy 19 Nov 2021
Value US$24,960.00 | Price 4.80 | Shares 5,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-08 2025-01-06 B Purchase
1.4
Sailer Carl
Non-Executive Director
29,323 +33.2%
57.10
US$3,074,389 		29,323 +33.2% 57.10 US$3,074,389
2025-01-08 2025-01-06 B Purchase
0.5
Donohue James J.
Non-Executive Director
10,979 -36.2%
304.16
US$2,953,103 		10,979 -36.2% 304.16 US$2,953,103
2025-01-08 2025-01-06 B Purchase
0.5
DEAN JACK H
Non-Executive Director
87,107 +11.3%
109.02
US$2,918,704 		87,107 +11.3% 109.02 US$2,918,704
2025-01-08 2025-01-06 B Purchase
1.6
Scodari Joseph C
Non-Executive Director
24,631 +800.5%
1.02
US$25,000 		24,631 +800.5% 1.02 US$25,000
2025-01-08 2025-01-06 B Purchase
1.4
LUCI DAVID P

President and CEO

Executive Director Large shareholder
49,261 +4.7%
1.02
US$50,000 		49,261 +4.7% 1.02 US$50,000
2025-01-08 2025-01-06 B Purchase
1.4
DELUCCIA ROBERT J
Non-Executive Director Large shareholder
49,261 +5.1%
1.02
US$50,000 		49,261 +5.1% 1.02 US$50,000
2022-07-29 2022-07-27 B Purchase
1.4
DELUCCIA ROBERT J
Non-Executive Director Large shareholder
19,737 +1.9%
3.80
US$75,001 		19,737 +1.9% 3.80 US$75,001
2022-07-29 2022-07-27 B Purchase
1.4
Sailer Carl
Non-Executive Director
19,737 +27.0%
3.80
US$75,001 		19,737 +27.0% 3.80 US$75,001
2022-07-29 2022-07-27 B Purchase
1.4
LUCI DAVID P

President and CEO

Executive Director Large shareholder
19,737 +2.0%
3.80
US$75,001 		19,737 +2.0% 3.80 US$75,001
2021-11-24 2021-11-23 B Purchase
1.4
Sailer Carl
Non-Executive Director
5,161 +7.6%
4.84
US$24,979 		5,161 +7.6% 4.84 US$24,979
2021-11-22 2021-11-19 B Purchase
1.4
DELUCCIA ROBERT J
Non-Executive Director Large shareholder
5,034 +0.5%
4.90
US$24,672 		5,034 +0.5% 4.90 US$24,672
2021-11-22 2021-11-19 B Purchase
1.4
LUCI DAVID P

President and CEO

Executive Director Large shareholder
5,200 +0.5%
4.80
US$24,960 		5,200 +0.5% 4.80 US$24,960
Explore more

More insider trading research around Acurx Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America